87 related articles for article (PubMed ID: 20920472)
21. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.
Cline GW; Petersen KF; Krssak M; Shen J; Hundal RS; Trajanoski Z; Inzucchi S; Dresner A; Rothman DL; Shulman GI
N Engl J Med; 1999 Jul; 341(4):240-6. PubMed ID: 10413736
[TBL] [Abstract][Full Text] [Related]
22. Muscle glycogen content in type 2 diabetes mellitus.
He J; Kelley DE
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E1002-7. PubMed ID: 15251866
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial function in skeletal muscle in type 2 diabetes.
Rabøl R
Dan Med Bull; 2011 Apr; 58(4):B4272. PubMed ID: 21466770
[TBL] [Abstract][Full Text] [Related]
24. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin decreases pyruvate dehydrogenase kinase 4 gene expression in obese- and diabetic-derived myotubes.
McAinch AJ; Cameron-Smith D
Diabetes Obes Metab; 2009 Jul; 11(7):721-8. PubMed ID: 19527483
[TBL] [Abstract][Full Text] [Related]
26. Type 2 diabetes mellitus and skeletal muscle metabolic function.
Phielix E; Mensink M
Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
[TBL] [Abstract][Full Text] [Related]
27. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
[TBL] [Abstract][Full Text] [Related]
28. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.
Abu Bakar MH; Sarmidi MR
Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959
[TBL] [Abstract][Full Text] [Related]
29. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes.
Zorzano A; Liesa M; Palacín M
Int J Biochem Cell Biol; 2009 Oct; 41(10):1846-54. PubMed ID: 19703653
[TBL] [Abstract][Full Text] [Related]
30. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
31. Control of skeletal muscle mitochondria respiration by adenine nucleotides: differential effect of ADP and ATP according to muscle contractile type in pigs.
Gueguen N; Lefaucheur L; Fillaut M; Vincent A; Herpin P
Comp Biochem Physiol B Biochem Mol Biol; 2005 Feb; 140(2):287-97. PubMed ID: 15649776
[TBL] [Abstract][Full Text] [Related]
32. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
[TBL] [Abstract][Full Text] [Related]
33. cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes.
Mitsuishi M; Miyashita K; Itoh H
Biochem Biophys Res Commun; 2008 Mar; 367(4):840-5. PubMed ID: 18194668
[TBL] [Abstract][Full Text] [Related]
34. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.
Gaster M; Rustan AC; Aas V; Beck-Nielsen H
Diabetes; 2004 Mar; 53(3):542-8. PubMed ID: 14988236
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants.
Abdul-Ghani MA; Jani R; Chavez A; Molina-Carrion M; Tripathy D; Defronzo RA
Diabetologia; 2009 Apr; 52(4):574-82. PubMed ID: 19183935
[TBL] [Abstract][Full Text] [Related]
36. Effect of serial cell passaging in the retention of fiber type and mitochondrial content in primary human myotubes.
Covington JD; Myland CK; Rustan AC; Ravussin E; Smith SR; Bajpeyi S
Obesity (Silver Spring); 2015 Dec; 23(12):2414-20. PubMed ID: 26538189
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.
Thingholm TE; Bak S; Beck-Nielsen H; Jensen ON; Gaster M
Mol Cell Proteomics; 2011 Sep; 10(9):M110.006650. PubMed ID: 21697546
[TBL] [Abstract][Full Text] [Related]
38. Altered mitochondrial network morphology and regulatory proteins in mitochondrial quality control in myotubes from severely obese humans with or without type 2 diabetes.
Gundersen AE; Kugler BA; McDonald PM; Veraksa A; Houmard JA; Zou K
Appl Physiol Nutr Metab; 2020 Mar; 45(3):283-293. PubMed ID: 31356754
[TBL] [Abstract][Full Text] [Related]
39. Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells.
Aguer C; Gambarotta D; Mailloux RJ; Moffat C; Dent R; McPherson R; Harper ME
PLoS One; 2011; 6(12):e28536. PubMed ID: 22194845
[TBL] [Abstract][Full Text] [Related]
40. Modeling and Phenotyping Acute and Chronic Type 2 Diabetes Mellitus In Vitro in Rodent Heart and Skeletal Muscle Cells.
Kopp EL; Deussen DN; Cuomo R; Lorenz R; Roth DM; Mahata SK; Patel HH
Cells; 2023 Dec; 12(24):. PubMed ID: 38132105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
